
Jerry B. Dennison
Examiner (ID: 40, Phone: (571)272-3910 , Office: P/2443 )
| Most Active Art Unit | 2443 |
| Art Unit(s) | 2443, 2409, 2143, 2419 |
| Total Applications | 1015 |
| Issued Applications | 700 |
| Pending Applications | 74 |
| Abandoned Applications | 250 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17426896
[patent_doc_number] => 20220054604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => Stabilised Compositions of Factor VII Polypeptides
[patent_app_type] => utility
[patent_app_number] => 17/231769
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23807
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231769
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/231769 | Stabilised Compositions of Factor VII Polypeptides | Apr 14, 2021 | Abandoned |
Array
(
[id] => 18451484
[patent_doc_number] => 20230192762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => Keratin Filament Networks
[patent_app_type] => utility
[patent_app_number] => 17/917425
[patent_app_country] => US
[patent_app_date] => 2021-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11269
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17917425
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/917425 | Keratin Filament Networks | Apr 12, 2021 | Pending |
Array
(
[id] => 17460590
[patent_doc_number] => 20220073895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => HUMAN COAGULATION FACTOR VII POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/228130
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28245
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17228130
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/228130 | HUMAN COAGULATION FACTOR VII POLYPEPTIDES | Apr 11, 2021 | Abandoned |
Array
(
[id] => 18436428
[patent_doc_number] => 20230183722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => GENE EXPRESSION SYSTEM FOR RAPID CONSTRUCTION OF MULTIPLE-GENE PATHWAY IN OLEAGINOUS YEASTS
[patent_app_type] => utility
[patent_app_number] => 17/995624
[patent_app_country] => US
[patent_app_date] => 2021-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995624
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995624 | GENE EXPRESSION SYSTEM FOR RAPID CONSTRUCTION OF MULTIPLE-GENE PATHWAY IN OLEAGINOUS YEASTS | Apr 6, 2021 | Pending |
Array
(
[id] => 17399946
[patent_doc_number] => 20220042036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => METHODS AND COMPOSITIONS FOR PREPARING SURFACTANT PROTEIN D (SP-D)
[patent_app_type] => utility
[patent_app_number] => 17/212895
[patent_app_country] => US
[patent_app_date] => 2021-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12513
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17212895
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/212895 | METHODS AND COMPOSITIONS FOR PREPARING SURFACTANT PROTEIN D (SP-D) | Mar 24, 2021 | Abandoned |
Array
(
[id] => 19158035
[patent_doc_number] => 20240150742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => GENE FOR EFFICIENTLY EXPRESSING HYALURONIC ACID HYDROLASE AND EXPRESSION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/280403
[patent_app_country] => US
[patent_app_date] => 2021-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5682
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18280403
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/280403 | GENE FOR EFFICIENTLY EXPRESSING HYALURONIC ACID HYDROLASE AND EXPRESSION METHOD THEREOF | Mar 22, 2021 | Pending |
Array
(
[id] => 17050538
[patent_doc_number] => 20210259972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => THROMBOLYTIC MICROSPHERES TO DISSOLVE VASO-OCCLUSIVE CLOTS
[patent_app_type] => utility
[patent_app_number] => 17/208736
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16663
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17208736
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/208736 | THROMBOLYTIC MICROSPHERES TO DISSOLVE VASO-OCCLUSIVE CLOTS | Mar 21, 2021 | Abandoned |
Array
(
[id] => 18293644
[patent_doc_number] => 20230103330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => MECHANISTIC BIOMARKER FOR PREDICTING THE SURVIVAL OF PANCREATIC CANCER PATIENTS
[patent_app_type] => utility
[patent_app_number] => 17/909908
[patent_app_country] => US
[patent_app_date] => 2021-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12439
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17909908
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/909908 | MECHANISTIC BIOMARKER FOR PREDICTING THE SURVIVAL OF PANCREATIC CANCER PATIENTS | Mar 17, 2021 | Pending |
Array
(
[id] => 17853148
[patent_doc_number] => 20220283190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => METHODS AND DEVICES FOR DETECTION OF COAGULATION IMPAIRMENT
[patent_app_type] => utility
[patent_app_number] => 17/195615
[patent_app_country] => US
[patent_app_date] => 2021-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27190
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17195615
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/195615 | METHODS AND DEVICES FOR DETECTION OF COAGULATION IMPAIRMENT | Mar 7, 2021 | Abandoned |
Array
(
[id] => 18871401
[patent_doc_number] => 11859190
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Methods and compositions for regulation of transgene expression
[patent_app_type] => utility
[patent_app_number] => 17/190994
[patent_app_country] => US
[patent_app_date] => 2021-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 24
[patent_no_of_words] => 21762
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 711
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17190994
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/190994 | Methods and compositions for regulation of transgene expression | Mar 2, 2021 | Issued |
Array
(
[id] => 18264946
[patent_doc_number] => 20230086188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => PROTEINS WITH PREDICTABLE LIQUID-LIQUID PHASE SEPARATION
[patent_app_type] => utility
[patent_app_number] => 17/908427
[patent_app_country] => US
[patent_app_date] => 2021-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33230
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908427
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/908427 | PROTEINS WITH PREDICTABLE LIQUID-LIQUID PHASE SEPARATION | Mar 2, 2021 | Pending |
Array
(
[id] => 17095739
[patent_doc_number] => 20210283530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => METHOD OF PURIFYING THERAPEUTIC PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/188173
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188173
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/188173 | METHOD OF PURIFYING THERAPEUTIC PROTEINS | Feb 28, 2021 | Pending |
Array
(
[id] => 18333873
[patent_doc_number] => 20230125821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => MODIFIED TRANSGLUTAMINASE
[patent_app_type] => utility
[patent_app_number] => 17/908761
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12258
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 613
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908761
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/908761 | MODIFIED TRANSGLUTAMINASE | Feb 25, 2021 | Pending |
Array
(
[id] => 19700200
[patent_doc_number] => 12194200
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-14
[patent_title] => Silk fibroin-based microneedles and methods of making the same
[patent_app_type] => utility
[patent_app_number] => 17/173289
[patent_app_country] => US
[patent_app_date] => 2021-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 37
[patent_no_of_words] => 24169
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17173289
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/173289 | Silk fibroin-based microneedles and methods of making the same | Feb 10, 2021 | Issued |
Array
(
[id] => 18226501
[patent_doc_number] => 20230065495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => MULTIPARTITE AND CIRCULARLY PERMUTED BETA-BARREL POLYPEPTIDES AND METHODS FOR THEIR USE
[patent_app_type] => utility
[patent_app_number] => 17/760165
[patent_app_country] => US
[patent_app_date] => 2021-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16672
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17760165
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/760165 | MULTIPARTITE AND CIRCULARLY PERMUTED BETA-BARREL POLYPEPTIDES AND METHODS FOR THEIR USE | Feb 4, 2021 | Abandoned |
Array
(
[id] => 16848195
[patent_doc_number] => 20210148940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => METHOD FOR SEPARATING TARGET MOLECULES OR PARTICLES FROM FIBRINOGEN-CONTAINING SAMPLES INCLUDING BLOOD COMPONENTS
[patent_app_type] => utility
[patent_app_number] => 17/160814
[patent_app_country] => US
[patent_app_date] => 2021-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9411
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17160814
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/160814 | METHOD FOR SEPARATING TARGET MOLECULES OR PARTICLES FROM FIBRINOGEN-CONTAINING SAMPLES INCLUDING BLOOD COMPONENTS | Jan 27, 2021 | Abandoned |
Array
(
[id] => 18649773
[patent_doc_number] => 20230295594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => METHOD FOR THE EFFICIENT EXPRESSION AND PURIFICATION AND APPLICATION OF A RECOMBINANT FUSION PROTEIN OF MANNASE AND HOMOLOGUES THEREOF AND GLP-1
[patent_app_type] => utility
[patent_app_number] => 18/020429
[patent_app_country] => US
[patent_app_date] => 2021-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5711
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18020429
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/020429 | METHOD FOR THE EFFICIENT EXPRESSION AND PURIFICATION AND APPLICATION OF A RECOMBINANT FUSION PROTEIN OF MANNASE AND HOMOLOGUES THEREOF AND GLP-1 | Jan 25, 2021 | Pending |
Array
(
[id] => 17052173
[patent_doc_number] => 20210261607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => PURIFICATION OF CHIMERIC FVIII MOLECULES
[patent_app_type] => utility
[patent_app_number] => 17/155935
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17155935
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/155935 | Purification of chimeric FVIII molecules | Jan 21, 2021 | Issued |
Array
(
[id] => 18567105
[patent_doc_number] => 20230257434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => CELL-DERIVED VESICLES COMPRISING TARGET PROTEIN AND METHOD FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 17/758825
[patent_app_country] => US
[patent_app_date] => 2021-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8935
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17758825
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/758825 | CELL-DERIVED VESICLES COMPRISING TARGET PROTEIN AND METHOD FOR PRODUCING SAME | Jan 12, 2021 | Abandoned |
Array
(
[id] => 18468833
[patent_doc_number] => 20230203115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => THERAPEUTIC COMPOSITIONS COMPRISING GRAFT MATERIALS AND BETA-TCP BINDING PEPTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/908835
[patent_app_country] => US
[patent_app_date] => 2021-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67276
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -61
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908835
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/908835 | THERAPEUTIC COMPOSITIONS COMPRISING GRAFT MATERIALS AND BETA-TCP BINDING PEPTIDES AND USES THEREOF | Jan 4, 2021 | Abandoned |